Bioharvest Sciences Inc (BHSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 198 | 192 | 194 | 190 | 136 |
| Accounts receivable | 153 | -366 | -39 | -53 | -130 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 39 |
| Other Working Capital | 604 | -346 | 26 | 410 | -398 |
| Other Operating Activity | -2,610 | -1,984 | -2,679 | -2,283 | -2,150 |
| Operating Cash Flow | $-1,655 | $-2,504 | $-2,498 | $-1,736 | $-2,503 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -376 | -263 | -279 | -323 | -391 |
| Investing Cash Flow | $-376 | $-263 | $-279 | $-323 | $-391 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 700 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 2,351 | N/A | N/A | N/A |
| Debt Repayment | -83 | -83 | -84 | -89 | -103 |
| Other Financing Activity | 0 | -37 | 3,919 | 2,118 | 146 |
| Financing Cash Flow | $617 | $2,231 | $3,835 | $2,029 | $43 |
| Exchange Rate Effect | -22 | 0 | 0 | -22 | 0 |
| Beginning Cash Position | 1,736 | 2,272 | 1,214 | 1,266 | 4,117 |
| End Cash Position | 300 | 1,736 | 2,272 | 1,214 | 1,266 |
| Net Cash Flow | $-1,414 | $-536 | $1,058 | $-30 | $-2,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,655 | -2,504 | -2,498 | -1,736 | -2,503 |
| Capital Expenditure | -376 | -263 | -279 | -323 | -391 |
| Free Cash Flow | -2,031 | -2,767 | -2,777 | -2,059 | -2,894 |